Skip to main content
. 2012 May 1;1(3):298–305. doi: 10.4161/onci.19068

graphic file with name onci-1-298-g3.jpg

Figure 3. CNS-1 cells (200,000 cells per well) were exposed for 24 hours to increasing concentrations per well of either resiquimod (A), or CY (B). Viability was measured (in triplicate) in a standard (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) bromide assay, and was expressed as a percentage of viability measured for cells cultured in medium only (control). Representative data of two experiments are shown.